Article Cited by others

INVITED REVIEW

Androgen effects on skeletal muscle: implications for the development and management of frailty

O«SQ»Connell Matthew DL, Wu Frederick CW

Year : 2014| Volume: 16| Issue : 2 | Page no: 203-212

   This article has been cited by
 
1 Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges
Xuelian Sun,Qiukui Hao,Renjie Tang,Chun Xiao,Meiling Ge,Birong Dong
Rejuvenation Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Testosterone Replacement Therapy and Rehospitalization in Older Men With Testosterone Deficiency in a Postacute Care Setting
Rasha A. Al-Lami,James E. Graham,Rachel R. Deer,Jordan Westra,Stephen B. Williams,Yong-Fang Kuo,Jacques Baillargeon
American Journal of Physical Medicine & Rehabilitation. 2019; 98(6): 456
[Pubmed]  [Google Scholar] [DOI]
3 ß-arrestin 1 regulates ß2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility
Jihee Kim,Chad A. Grotegut,James W. Wisler,Tianyu Li,Lan Mao,Minyong Chen,Wei Chen,Paul B. Rosenberg,Howard A. Rockman,Robert J. Lefkowitz
Skeletal Muscle. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
4 Get a grip: Individual variations in grip strength are a marker of brain health
Richard G. Carson
Neurobiology of Aging. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Mesenchymal Stem Cell Therapy for Aging Frailty
Ivonne Hernandez Schulman,Wayne Balkan,Joshua M. Hare
Frontiers in Nutrition. 2018; 5
[Pubmed]  [Google Scholar] [DOI]
6 Testosterone, frailty and physical function in older men
Benjumin Hsu,Robert G. Cumming,David J. Handelsman
Expert Review of Endocrinology & Metabolism. 2018; 13(3): 159
[Pubmed]  [Google Scholar] [DOI]
7 A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors
Robert S. English
Medical Hypotheses. 2018; 111: 73
[Pubmed]  [Google Scholar] [DOI]
8 Detection of SARMs in doping control analysis
Mario Thevis,Wilhelm Schänzer
Molecular and Cellular Endocrinology. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes
Mario Thevis,Thomas Piper,Josef Dib,Andreas Lagojda,Dirk Kühne,Lars Packschies,Hans Geyer,Wilhelm Schänzer
Rapid Communications in Mass Spectrometry. 2017; 31(14): 1175
[Pubmed]  [Google Scholar] [DOI]
10 Evaluation and management of frailty
Chang Won Won
Journal of the Korean Medical Association. 2017; 60(4): 314
[Pubmed]  [Google Scholar] [DOI]
11 Role of Nuclear Receptors in Exercise-Induced Muscle Adaptations
Barbara Kupr,Svenia Schnyder,Christoph Handschin
Cold Spring Harbor Perspectives in Medicine. 2017; 7(6): a029835
[Pubmed]  [Google Scholar] [DOI]
12 Is It Time to Begin a Public Campaign Concerning Frailty and Pre-frailty? A Review Article
Jerzy Sacha,Magdalena Sacha,Jacek Sobon,Zbigniew Borysiuk,Piotr Feusette
Frontiers in Physiology. 2017; 8
[Pubmed]  [Google Scholar] [DOI]
13 Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
Abdulmaged M. Traish
Sexual Medicine Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]
14 Low Testosterone Levels Result in Decreased Periurethral Vascularity via an Androgen Receptor-Mediated Process: Pilot Study in Urethral Stricture Tissue
Matthias D. Hofer,Payal Kapur,Billy H. Cordon,Farrah Hamoun,David Russel,Jeremy M. Scott,Claus G. Roehrborn,Allen F. Morey
Urology. 2017;
[Pubmed]  [Google Scholar] [DOI]
15 Testosterone and Physical Function
Swaytha Yalamanchi,Rita R. Kalyani,Brian Buta,Adrian Dobs
Current Sexual Health Reports. 2017; 9(4): 296
[Pubmed]  [Google Scholar] [DOI]
16 Body Composition changes with Testosterone Replacement Therapy following Spinal Cord Injury and Aging. A Mini Review
Tom E Nightingale,Pamela Moore,Joshua Harman,Refka Khalil,Ranjodh S Gill,Teodoro Castillo,Robert A Adler,Ashraf S Gorgey
The Journal of Spinal Cord Medicine. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
17 Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults
Javier Angulo,Mariam El Assar,Leocadio Rodríguez-Mañas
Molecular Aspects of Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]
18 Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle
V. J. Dalbo,M. D. Roberts,C. B. Mobley,C. Ballmann,W. C. Kephart,C. D. Fox,V. A. Santucci,C. F. Conover,L. A. Beggs,A. Balaez,F. J. Hoerr,J. F. Yarrow,S. E. Borst,D. T. Beck
Andrologia. 2016;
[Pubmed]  [Google Scholar] [DOI]
19 Identification of Selected in vitro-Generated Phase-I Metabolites of the Steroidal Selective Androgen Receptor Modulator MK-0773 for Doping Control Purposes
Andreas Lagojda,Dirk Kuehne,Oliver Krug,Andreas Thomas,Tina Wigger,Uwe Karst,Wilhelm Schänzer,Mario Thevis
European Journal of Mass Spectrometry. 2016; 22(2): 49
[Pubmed]  [Google Scholar] [DOI]
20 Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men
Stephen E. Borst,Joshua F. Yarrow
American Journal of Physiology-Endocrinology and Metabolism. 2015; 308(12): E1035
[Pubmed]  [Google Scholar] [DOI]
21 Molecular Targets of Androgen Signaling that Characterize Skeletal Muscle Recovery and Regeneration
James G. MacKrell,Benjamin C. Yaden,Heather Bullock,Keyue Chen,Pamela Shetler,Henry U. Bryant,Venkatesh Krishnan
Nuclear Receptor Signaling. 2015; 13(1): nrs.13005
[Pubmed]  [Google Scholar] [DOI]
22 Androgen receptor activation integrates complex transcriptional effects in osteoblasts, involving the growth factors TGF-ß and IGF-I, and transcription factor C/EBPd
Thomas L. McCarthy,Michael Centrella
Gene. 2015; 573(1): 129
[Pubmed]  [Google Scholar] [DOI]
23 Roles of the Androgen – Androgen Receptor System in Vascular Angiogenesis
Sumiko Yoshida,Yasumasa Ikeda,Ken-ichi Aihara
Journal of Atherosclerosis and Thrombosis. 2015;
[Pubmed]  [Google Scholar] [DOI]
24 3-Alkoxy-pyrrolo[1,2-b]pyrazolines as Selective Androgen Receptor Modulators with Ideal Physicochemical Properties for Transdermal Administration
Thomas Ullrich,Sanjita Sasmal,Venkatesham Boorgu,Srinivasu Pasagadi,Srisailam Cheera,Sujatha Rajagopalan,Archana Bhumireddy,Dhanya Shashikumar,Shekar Chelur,Charamanna Belliappa,Chetan Pandit,Narasimharao Krishnamurthy,Subhendu Mukherjee,Anuradha Ramanathan,Chakshusmathi Ghadiyaram,Murali Ramachandra,Paulo G. Santos,Bharat Lagu,Mark G. Bock,Mark H. Perrone,Sven Weiler,Hansjoerg Keller
Journal of Medicinal Chemistry. 2014; 57(17): 7396
[Pubmed]  [Google Scholar] [DOI]

 

Read this article